Boston Scientific (BSX) said Monday it has agreed to acquire Cortex, a privately-held medical technology firm.
The transaction is expected to close in H1 2025, subject to customary conditions, Boston Scientific said, adding that the deal is projected to have minimal impact on its 2025 adjusted earnings per share.
Financial terms were not disclosed.
Boston Scientific shares were up 1.6% in recent trading.
Price: 84.99, Change: +1.37, Percent Change: +1.64
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.